BOSTON (TheStreet) — A single individual used three different pseudonyms to publish articles on Seeking Alpha touting Galena Biopharma (GALE) and other biotech stocks.
Seeking Alpha removed five articles from its web site Sunday, all of which included an identical paragraph about Galena and its experimental breast cancer vaccine Neuvax. The articles, published over the past two months, appeared to have been written by three different people all under the cloak of anonymity using the aliases Elegant Trader, Momentum Trading and Thomas Option Hunter.
After looking into the matter, Seeking Alpha discovered that a single individual wrote all five articles.
REALLY MAKES YOU WONDER
Sentiment: Strong Sell
You three guys are really pathetic. If you guys were short and dumb enough to not have gotten out by now, then I would say that you should give up and go try to get a job for the National Enquirer.....At least there, your comical writing might be appreciated by the droll that read the rag. For here, your intelligence, or lack there of is nothing more than annoying......blah blah and more blah.